Are Portable Lactate Monitoring Devices Accurate in Patients with Glycogen Storage Disease Ia When Compared to Blood Serum Lactates?

Description

The goal of this observational study is to determine if home lactate meters (both capillary and serum sample) are accurate, compared to lab serum lactate in a population of patients with glycogen storage disease type 1a and to determine if the Accu Chek Guide glucometer (capillary sample) is accurate, in a population of patients with glycogen storage disease type 1a.

Conditions

Glycogen Storage Disease Type Ia

Study Overview

Study Details

Study overview

The goal of this observational study is to determine if home lactate meters (both capillary and serum sample) are accurate, compared to lab serum lactate in a population of patients with glycogen storage disease type 1a and to determine if the Accu Chek Guide glucometer (capillary sample) is accurate, in a population of patients with glycogen storage disease type 1a.

Are Portable Lactate Monitoring Devices Accurate in Patients with Glycogen Storage Disease Ia When Compared to Blood Serum Lactates?

Are Portable Lactate Monitoring Devices Accurate in Patients with Glycogen Storage Disease Ia When Compared to Blood Serum Lactates?

Condition
Glycogen Storage Disease Type Ia
Intervention / Treatment

-

Contacts and Locations

Hartford

Connecticut Children's Medical Center, Hartford, Connecticut, United States, 06107

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Patients with diagnosed/confirmed (by liver biopsy or genetic testing) Glycogen Storage Disease Type Ia (ICD 10 code: E74.01).
  • * Connecticut Children's Emergency Department visit and/or admission to Connecticut Children's during time study is active
  • * For pediatric participants: Ability of child's parent/legal guardian to understand and the willingness to sign a written informed consent document
  • * For adults: Ability to understand and the willingness to sign a written informed consent
  • * Patients with Glycogen storage disease unspecified 74.00, or Ib
  • * Patients not meeting inclusion criteria

Ages Eligible for Study

0 Years to 60 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Connecticut Children's Medical Center,

Study Record Dates

2026-03-10